Stock Analysis

High Growth Tech Stocks to Watch in Asia November 2025

As global markets grapple with fluctuating consumer sentiment and economic uncertainties, Asian tech stocks have shown resilience, particularly as easing U.S.-China trade tensions provide a more favorable backdrop for growth. In this dynamic environment, identifying promising high-growth tech stocks involves assessing their adaptability to market shifts and their potential to leverage technological advancements effectively.

Advertisement

Top 10 High Growth Tech Companies In Asia

NameRevenue GrowthEarnings GrowthGrowth Rating
Giant Network Group34.13%39.54%★★★★★★
Suzhou TFC Optical Communication34.08%35.52%★★★★★★
Shengyi TechnologyLtd21.50%32.87%★★★★★★
Zhongji Innolight30.75%31.56%★★★★★★
ASROCK Incorporation29.29%31.08%★★★★★★
Fositek36.92%48.42%★★★★★★
Gold Circuit Electronics26.88%35.34%★★★★★★
eWeLLLtd25.02%24.93%★★★★★★
ALTEOGEN56.27%65.14%★★★★★★
CARsgen Therapeutics Holdings100.40%118.16%★★★★★★

Click here to see the full list of 187 stocks from our Asian High Growth Tech and AI Stocks screener.

Let's review some notable picks from our screened stocks.

Gan & Lee Pharmaceuticals (SHSE:603087)

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Gan & Lee Pharmaceuticals is a biopharmaceutical company focused on the research, development, production, and sale of insulin analog APIs and injections in China with a market capitalization of CN¥38.16 billion.

Operations: The company primarily generates revenue through the development, production, and sale of insulin and related products, amounting to CN¥3.85 billion.

Gan & Lee Pharmaceuticals has demonstrated robust financial and operational growth, with a notable 59.4% increase in earnings over the past year, outpacing its industry's average. The company's commitment to innovation is evident in its R&D investments, which have positioned it as a leader in developing treatments for metabolic diseases. Recent strategic moves include appointing Dr. Ting Jia as CMO to spearhead global clinical strategies and signing significant agreements with Brazilian health entities, ensuring long-term revenue streams from insulin products critical for diabetes care. These initiatives not only enhance Gan & Lee's market position but also align with broader health system resilience goals, potentially setting new standards in pharmaceutical supply chains across emerging markets.

SHSE:603087 Revenue and Expenses Breakdown as at Nov 2025
SHSE:603087 Revenue and Expenses Breakdown as at Nov 2025

Integrity Technology Group (SHSE:688244)

Simply Wall St Growth Rating: ★★★★★☆

Overview: Integrity Technology Group Inc. is a network security enterprise offering solutions in China, with a market cap of CN¥3.11 billion.

Operations: Integrity Technology Group Inc. specializes in providing network security solutions within China.

Integrity Technology Group, navigating through a challenging fiscal period, reported a significant downturn with sales dropping to CNY 142.29 million from CNY 172.94 million year-over-year and net losses widening to CNY 54.85 million from CNY 31.58 million. Despite these setbacks, the company is poised for recovery with projected revenue growth of 24.7% annually, outstripping the Chinese market's average of 14.4%. This optimism is bolstered by forecasts suggesting profitability within three years, supported by strategic shifts likely aimed at enhancing product offerings and market adaptability in the fast-evolving tech landscape.

SHSE:688244 Revenue and Expenses Breakdown as at Nov 2025
SHSE:688244 Revenue and Expenses Breakdown as at Nov 2025

Rakus (TSE:3923)

Simply Wall St Growth Rating: ★★★★★☆

Overview: Rakus Co., Ltd. and its subsidiaries offer cloud services in Japan, with a market capitalization of ¥435.40 billion.

Operations: The company specializes in providing cloud services in Japan. With a market capitalization of ¥435.40 billion, it operates through various revenue streams without detailed segment information available.

Rakus Co., Ltd. is making significant strides in the competitive tech landscape of Asia, evidenced by a robust sales performance with recent monthly figures consistently above JPY 4,900 million. The company's strategic alliance with Plus Alpha Consulting aims to enhance its SaaS offerings, potentially boosting customer satisfaction and market share. Notably, Rakus's forward-looking financials are promising; it anticipates a revenue growth of 15.8% annually and earnings growth at an impressive 23.3% per year, outpacing the Japanese market averages significantly. This growth trajectory is underpinned by high-quality past earnings and an aggressive R&D investment strategy that aligns with its expansion goals in cloud services and back-office solutions, marking it as a dynamic player in Asia's high-growth tech sector.

TSE:3923 Earnings and Revenue Growth as at Nov 2025
TSE:3923 Earnings and Revenue Growth as at Nov 2025

Seize The Opportunity

Curious About Other Options?

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

New: AI Stock Screener & Alerts

Our new AI Stock Screener scans the market every day to uncover opportunities.

• Dividend Powerhouses (3%+ Yield)
• Undervalued Small Caps with Insider Buying
• High growth Tech and AI Companies

Or build your own from over 50 metrics.

Explore Now for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com